BIEL as a Real World VC Lesson for Young Investors — The

New Post Public Reply Private Reply Replies (0) Message Board
Bielionaire
223
BIEL as a Real World VC Lesson for Young Investors — The North Carolina Connection
Open Letter to Jimmy “MrBeast” Donaldson - 27-year-old YouTuber with 469M subscribers and 1.4B people watching his content—more than anyone else on Earth.

Jimmy,
Before anything else, this is a North Carolina story.  You grew up in Greenville, NC. Ken Mayer—the founder of Electrome and the operator now steering BIEL’s commercialization—built his career from roots in North Carolina before scaling companies to nine figure exits. And BioElectronics Corp’s longtime chairman, Dr. Richard Staelin, is a Duke professor who spent decades shaping research, innovation, and entrepreneurship in the state.  Three people. Three different paths. All tied to North Carolina, all converging around a technology that could help millions.  That shared origin is the perfect foundation for teaching young investors how venture capital really works—through a real company, real technology, and a real catalyst.
 

Teaching Young Investors the Venture Capital Mindset Through BIEL
You’ve already shown millions of young people that money isn’t just something you spend—it’s something you build. With Step, you opened the door to financial literacy. The next evolution is teaching the mindset behind venture capital: spotting undervalued opportunities, understanding asymmetric risk, and learning how tiny investments can create life changing returns.  That’s where BioElectronics Corp (BIEL) becomes the perfect real world case study.

BIEL is a Venture Capital Type Opportunity Anyone Can Afford
Most teens can’t buy into early stage startups or private deals. But they can buy shares of a micro cap company trading for a fraction of a penny.

BIEL sits around $0.0003, which means:
• $1 buys over 3,000 shares
• $10 buys over 30,000 shares
• $100 buys over 300,000 shares
It’s the closest thing to “venture investing for everyone,” because the barrier to entry is almost zero—but the upside, if the thesis plays out, is enormous.  This teaches the core VC lesson:  Small checks + high conviction + long time horizon = asymmetric ROI.
 
The Real Story: BIEL + Electrome = A Technical Marriage With Massive Optionality
BIEL isn’t just a cheap stock. It’s a company with a validated, FDA cleared technology—PEMF therapy—that already works in the real world. ActiPatch® uses micro pulses to calm pain signaling without drugs.  The “venture style” catalyst is the new partnership with Electrome, led by Ken Mayer, the North Carolina–rooted founder with a track record of scaling and exiting companies for nine figure sums.  Young investors get to see how a small company suddenly becomes part of a much bigger engine.

What makes this partnership a VC style inflection point:
• The Mayer Effect A proven operator with Mayo Clinic ties and AI driven therapy experience is taking BIEL’s tech from niche to mainstream.
• Minimum Purchase Commitments Electrome is guaranteeing volume—rare revenue predictability for a micro cap.
• Distribution + Data + AI BIEL provides the hardware; Electrome provides the intelligence and the go to market muscle.
This is exactly the kind of “technical marriage” VCs look for: a small company with great tech plugging into a larger company with scale.

Why This Fits Perfectly Into Your Mission of Teaching Young People to Invest
1. A Real World Lesson in High Risk, High Reward Investing
BIEL is a micro cap. It’s volatile. It’s speculative. But that’s the point—young investors learn how to evaluate risk, not avoid it.  You can show them how to:
• research a company
• understand catalysts
• think in probabilities, not guarantees
• size positions responsibly
It’s the safest way to teach the mindset of venture capital without needing accredited investor status.

2. A Humanitarian Story That Mirrors Your Brand
BIEL’s tech is about relieving chronic pain without opioids.  Imagine teaching financial literacy while also showing how investing can support technologies that help millions live pain free.

3. A David vs Goliath Narrative Young Investors Love
Retail investors already frame BIEL as the underdog fighting:
• Big Pharma
• institutional short sellers
• outdated medical gatekeeping
It’s the same energy as Step taking on traditional banks.

4. A Gamified, Educational Experience Through Step
You could turn this into a viral financial literacy moment:
• “Learn how to evaluate a micro cap.”
• “Build your first VC style portfolio.”
• “Understand asymmetric upside.”
You’re not telling kids to buy BIEL—you’re teaching them how to think.

The Story You Can Tell
“Most people think you need millions to invest like a venture capitalist. But what if you could learn the same skills with just a few dollars? Today I’m showing you how to analyze a real micro cap company with real technology and real upside—and how to think about risk the way professionals do.”  It’s educational. It’s empowering. It’s aligned with your mission. And it’s built around a real company with a real catalyst— and a shared North Carolina origin story that ties it all together.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 8

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Elah Holdings' Q3 2026 Report Sparks Investor Interest

Updated Category News Views 79

Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 101

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 10

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 128

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 99

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
ArcSpan AMS Nabs Top Honors at The Wires 2026

Updated Category News Views 159

ArcSpan Takes Center Stage with Prestigious Accolade ArcSpan just bagged the Best New Product or Service: Sell Side award at The Wires 2026. This ain't your average pat on the back. Taking place at the ritzy One Marylebone in London, this win springs from an event that celebrates the crème de la crème of digital advertising innovation. A Solid Win Amid The Changing Ad...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 208

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 229

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into National HealthCare Corporation by Kaskela Law

Updated Category News Views 203

Kaskela Law LLC Announces Investigation Kaskela Law LLC has recently launched an investigation into National HealthCare Corporation (NYSE: NHC) on behalf of its shareholders. This inquiry seeks to determine if the company or its executives have violated securities laws or breached their fiduciary duties in light of recent corporate actions. Investigation Objectives The...

Continue Reading
HOPE Therapeutics Expands Its Reach in Florida’s Mental Health Care

Updated Category News Views 161

HOPE Therapeutics Welcomes Cohen & Associates to the Network In an exciting advancement, HOPE Therapeutics, Inc. has recently integrated Cohen & Associates, LLC into its expanding professional framework, aimed at revolutionizing the landscape of interventional psychiatry. This noteworthy inclusion signals a meaningful step in enhancing mental health services across...

Continue Reading
Abdullah Abdin Ready Mix Concrete's Historic Certification Milestone

Updated Category News Views 217

Abdullah Abdin Ready Mix Concrete Announces Historic Achievement Setting new standards in sustainability and innovation, Abdullah Abdin Ready-Mix Concrete has proudly achieved the prestigious Concrete Sustainability Council (CSC) certification. This recognition establishes the company as the first ready-mix concrete firm in the MENA region to receive such an influential...

Continue Reading
The Tragic Shooting of Charlie Kirk: National Outrage Ensues

Updated Category News Views 393

The Shocking Assassination of Charlie Kirk Conservative political activist Charlie Kirk was tragically shot and killed while addressing a gathering. This shocking incident has ignited a series of investigations and public responses, leading to numerous political reactions across the nation. Details Surrounding the Incident The violent act took place during Kirk's speech,...

Continue Reading
Cibus Global Ltd. Faces Market Challenges with Stock Dip

Updated Category News Views 129

Cibus Global Ltd. Faces Significant Stock Decline In recent trading sessions, Cibus Global Ltd. (CBUS) stock encountered a dramatic decline, hitting a 52-week low of $2.36. This notable drop is stark when compared to its previous high of $23.18, showing a staggering reduction of approximately 88.48% over the past year. The plummeting share price has raised alarms among...

Continue Reading